secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0001213900-23-070108
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals regains Nasdaq compliance on bid price and equity requirements
--------------------------------------------------------------------------------

- Received Nasdaq notice on Aug 21, 2023, confirming minimum bid price compliance (Rule 5550(a)(2)) after 10 consecutive days at $1.00+.
- Received second notice on Aug 22, 2023, confirming regained compliance with stockholders' equity minimum of $2.5 million.
- All outstanding Nasdaq listing deficiencies are now resolved; the matters are closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390023070108/0001213900-23-070108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390023070108/ea184064-8k_adialpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-070108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer